Clinical Trial

Safety Evaluation of Bioactive Glass Based Bone Cement Combined With Ultrasound in Implantation for Metastatic Bone Tumors

Study acronym: SE-BGCU-MBT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study is evaluating the safety of using bioactive glass-containing bone cement combined with ultrasound during surgery for patients with metastatic bone tumors. We aim to see if this treatment can be safely applied to stabilize the bone and reduce pain, without causing unexpected side effects. All participants will receive standard care plus the study treatment, and we will closely monitor them during and after the procedure to check for any safety concerns.
Trial Details
NCT Number NCT07540468
Lead Sponsor Liao Yun
Conditions Advanced Cancer, Pain
Enrollment 8 participants
Start Date 2026-05-01
Primary Completion 2027-04-30 (estimated)
Study Completion 2028-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-20